Arkolith/Insider Trading/ATNF/Form 4

Feldmann Marc

Director180 Life Sciences Corp. (ATNF) · full profile →Form 4 · filed Dec 13, 2021
Net Buying
Open-Market Buys
$204K
Open-Market Sells
$0
Net Open-Market Flow
$204K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 9, 2021Buy(P)50K$4.07$204K2.8M
Dec 8, 2021Grant(A)6K$3.95$22K2.8M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 8, 2021Grant(A)25K—$025K

Transaction Codes

P
Open-market purchase
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-21-064981) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML